readthroughSign in
Sep 25, 2026People

Biotricity director Jainal Bhuiyan resigns from board and compensation committee

Biotricity said the departure, effective September 22, 2026, was unrelated to any disagreement with the company, and named a replacement to fill the resulting committee seat.

Biotricity Inc. disclosed in a Form 8-K dated September 25, 2026 that Jainal Bhuiyan notified the Board of Directors of Biotricity Inc. of his resignation as a member of the Board and as a member of the Compensation Committee, effective September 22, 2026.1

The company stated that the resignation was not tied to any disagreement with the company over its operations, policies, or practices.1 Bhuiyan's tenure dated back to when he began serving as a director of the company on August 15, 2024.1

With his exit, the Board now consists of three directors: Waqaas Al-Siddiq, David A. Rosa and Ronald McClurg.1 To fill the resulting gap, the Board appointed Ronald McClurg to the Compensation Committee.1 That change means the Compensation Committee is now made up of David A. Rosa, continuing as chairman, and Ronald McClurg.1

The filing noted that the makeup of the company's other two board committees did not change as a result of the resignation: the Audit Committee remains led by Ronald McClurg as chairman with David A. Rosa, and the Nominating and Corporate Governance Committee remains led by David A. Rosa as chairman with Ronald McClurg.1

Biotricity also said it has not yet decided whether it will fill the board seat left open by Bhuiyan's departure or instead shrink the board's overall size.1 The 8-K was signed on behalf of the company by Chief Financial Officer S. John Ayanoglou.

Written by readthrough’s AI from the linked primary sources and fact-checked against them automatically before publishing. Not investment advice.